DOLOBENE gel tb 50 g

7680459980103 CH-45998 C05BA53 02.08.2.
DOLOBENE gel tb 50 g
DOLOBENE gel tb 50 g
DOLOBENE gel tb 50 g
1 / 3
google

Details

Product number
4599801
CPT
-
Packaging group
50
Unit
g
Composition
heparinum natricum 500 U.I., dimethylis sulfoxidum 150 mg, dexpanthenolum 25 mg, propylenglycolum et aromatica, excipiens ad gelatum pro 1 g.

Articles (1)

Dolobene, Gel
Gel
50
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
01/04/2022
Patient information leaflet
Français
01/04/2022
Patient information leaflet
Italien
01/04/2022
Professional SmPC
Allemand
01/04/2022
Professional SmPC
Français
01/04/2022

Detailed composition

Substance Quantity Type Category
(N/A)
500.0 UI Substance Wirkstoff (Principe actif)
(N/A)
150.0 MG Substance Wirkstoff (Principe actif)
(N/A)
25.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
(N/A)
- Substance AROMA

Reimbursement information

Public price
CHF 7.45
Specialties list
Yes
Generic
No
SL addition date: 15/03/1993

Authorization holder

Mepha Pharma AG

4051 Basel

Authorization information

Swissmedic authorization number
45998
Drug name
Dolobene, Gel
Galenic form
GELK
ATC Code
C05BA53
Authorization status
Z
Dispensation category
D
First authorization
07/06/1984
Authorization expiration date
01/12/2025
IT number
02.08.2.
Domain
Human medicine
Field of application
Stumpfe Sportverletzungen, venöse Beinleiden

Packaging details

Description (FR)
DOLOBENE gel tb 50 g
Description (DE)
DOLOBENE Gel Tb 50 g
Market launch
07/06/1984
Market withdrawal
15/08/2025
Narcotic (BTM)
No